Enzolytics Inc. logo

Enzolytics Inc.

OTC:ENZC

Overview | Financials
Company Name Enzolytics Inc.
Symbol ENZC
Currency USD
Price 0.022
Market Cap 53,065,461
Dividend Yield 0%
52-week-range 0.016 - 0.132
Industry Biotechnology
Sector Healthcare
CEO Mr. Charles S. Cotropia
Website https://enzolytics.com

An error occurred while fetching data.

About Enzolytics Inc.

Enzolytics, Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics.

Related Stocks

Financials

Numbers are in millions USD

Numbers are in millions USD